2017 / 04

DOI: 10.24075/brsmu.2017-04-10

METHOD

Feasibility of using 6 MV photon beams in contrast-enhanced radiotherapy

Vorobyeva ES1, Lipengolts AA1,2,3, Cherepanov AA2, Grigorieva EYu2, Nechkina IN2, Kalygina NS2, Sokovikov AV4, Kulakov VN1, Sheino IN1
About authors

1 Laboratory of radiotherapy methods and technologies, Department of Medical Radiation Technologies,
A. I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia

2 Laboratory of radionuclide and radiation technologies in experimental oncology, Research Institute of Clinical and Experimental Radiology,
N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russia

3 National Research Nuclear University MEPhI, Moscow

4 MedService Ltd., Moscow, Russia

Correspondence should be addressed: Alexey A. Lipengolts
Kashirskoe shosse, d. 24, Moscow, Russia, 115478; ur.liam@stlognepil

About paper

All authors' contribution to this work is equal: selection and analysis of literature, research planning, data collection, analysis, and interpretation, drafting of a manuscript, editing.

Received: 2017-08-25 Accepted: 2017-08-30 Published online: 2017-10-31
|
  1. Kulakov VN, Lipengol’ts AA, Grigor’eva EY, Shimanovskii NL. Pharmaceuticals for Binary Radiotherapy and Their Use for Treatment of Malignancies (A Review). Pharm Chem J. 2016; 50 (6): 388–93.
  2. Hainfeld JF, Smilowitz HM, O’Connor MJ, Dilmanian FA, Slatkin DN. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine. 2013; 8 (10): 1601–9. DOI: 10.2217/nnm.12.165.
  3. Butterworth KT, Nicol JR, Ghita M, Rosa S, Chaudhary P, McGarry CK et al. Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy. Nanomedicine. 2016; 11 (16): 2035–47. DOI: 10.2217/nnm-2016-0062.
  4. Lipengolts AA, Cherepanov AA, Kulakov VN, Grigorieva EY, Sheino IN, Klimanov VA. Antitumor efficacy of extracellular complexes with gadolinium in Binary Radiotherapy. Appl Radiat Isot. 2015 Dec 1; 106: 233–6. DOI: 10.1016/j.apradiso.2015.07.051.
  5. Rose JH, Norman A, Ingram M, Aoki C, Solberg T, Mesa A. First radiotherapy of human metastatic brain tumors delivered by a computerized tomography scanner (CTRx). Int J Radiat Oncol Biol Phys. 1999; 45 (5): 1127–32.
  6. Cherepanov AA, Lipengolts AA, Nasonova TA, Dobrynina OA, Kulakov VN, Sheino IN et al. [Increasing of antineoplastic effect of x-ray irradiation in mice with transplanted melanoma B16F10 by use of gadolinium containing drug]. Meditsinskaya fizika. 2014; (3): 66–9. Russian.
  7. Bobyk L, Edouard M, Deman P, Vautrin M, Pernet-Gallay K, Delaroche J et al. Photoactivation of gold nanoparticles for glioma treatment. Nanomedicine. 2013 Oct; 9 (7): 1089–97. DOI: 10.1016/j.nano.2013.04.007.
  8. Wolfe T, Chatterjee D, Lee J, Grant JD, Bhattarai S, Tailor R et al. Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Nanomedicine. 2015 Jul; 11 (5): 1277–83. DOI: 10.1016/j.nano.2014.12.016.
  9. Detappe A, Kunjachan S, Drané P, Kotb S, Myronakis M, Biancur DE, et al. Key clinical beam parameters for nanoparticle-mediated radiation dose amplification. Sci Rep. 2016 Sep 23; 6 (1): 34040. DOI: 10.1038/srep34040.
  10. Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C, et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine. 2009 Jun; 5 (2) : 136–42.
  11. Chang MY, Shiau AL, Chen YH, Chang CJ, Chen HHW, Wu CL. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 2008 Jul; 99 (7): 1479–84. DOI: 10.1111/j.1349-7006.2008.00827.x.
  12. Rousseau J, Boudou C, Barth RF, Balosso J, Estève F, Elleaume H. Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res. 2007 Sep; 13 (17): 5195–201. DOI: 10.1158/1078-0432.CCR-07-1002.
  13. Detappe A, Kunjachan S, Rottmann J, Robar J, Tsiamas P, Korideck H, et al. AGuIX nanoparticles as a promising platform for image-guided radiation therapy. Cancer Nanotechnol. 2015; 6 (1): 4. DOI: 10.1186/s12645-015-0012-3.
  14. McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother Oncol. 2011 Sep; 100 (3): 412–6. DOI: 10.1016/j.radonc.2011.08.027.
  15. Lin Y, McMahon SJ, Scarpelli M, Paganetti H, Schuemann J. Comparing gold nano-particle enhanced radiotherapy with protons, megavoltage photons and kilovoltage photons: a Monte Carlo simulation. Phys Med Biol. 2014 Dec 21; 59 (24): 7675–89. DOI: 10.1088/0031-9155/59/24/7675.
  16. Tsiamas P, Liu B, Cifter F, Ngwa WF, Berbeco RI, Kappas C, et al. Impact of beam quality on megavoltage radiotherapy treatment techniques utilizing gold nanoparticles for dose enhancement. Phys Med Biol. 2013 Feb 7; 58 (3): 451–64. DOI: 10.1088/0031-9155/58/3/451.
  17. Kakade NR, Sharma SD. Dose enhancement in gold nanoparticle-aided radiotherapy for the therapeutic photon beams using Monte Carlo technique. J Cancer Res Ther. 2015 Jan–Mar; 11 (1): 94–7. DOI: 10.4103/0973-1482.147691.
  18. Smith CL, Ackerly T, Best SP, Gagliardi F, Kie K, Little PJ, et al. Determination of dose enhancement caused by gold-nanoparticles irradiated with proton, X-rays (kV and MV) and electron beams, using alanine/EPR dosimeters. Radiat Meas. 2015; 82: 122–8.
  19. Cherepanov AA, Lipengolts AA, Vorobyeva ES, Kulakov VN, Klimanov VA, Grigorieva EYu. [Experimental study of x-rays absorbed dose increase in medium containing high-Z element using Fricke dosimeter]. Meditsinskaya fizika. 2016; 72 (4): 38–41. Russian.
  20. Obeid L, Deman P, Tessier A, Balosso J, Estève F, Adam J-F. Absolute perfusion measurements and associated iodinated contrast agent time course in brain metastasis: a study for contrast-enhanced radiotherapy. J Cereb Blood Flow Metab. 2014 Apr; 34 (4) :638–45. DOI: 10.1038/jcbfm.2013.239.